The plastic tubes supplied for coronavirus testing by Fillakit, a first-time federal contractor with a sketchy owner, don’t even fit the racks used to analyze samples. And they may be contaminated anyway.
Everything Mary Savage did in the hours after the attack was dissected on the witness stand, an experience so upsetting she vomited. But years later, she finds comfort knowing her testimony led to his conviction.
Among the many ways to shorten the vaccine development timeline, approving a treatment based on antibody data — without completing a phase 3 trial — could be contentious. This is why.
It is likely we’ll eventually have a coronavirus vaccine — but perhaps not as quickly as some expect. From development, to clinical trials and distribution, ProPublica reporter Caroline Chen explains the tremendous challenges that lie ahead.
A nursing home in Troy, New York, followed the governor’s order to accept patients being treated for COVID-19. Six weeks later, 18 residents were dead of the disease.
General Motors received tens of millions of dollars in tax breaks to operate a massive assembly plant in Lordstown, Ohio, until 2027. The plant closed last year, and the state may force a repayment of more than $60 million, documents show.
ProPublica deputy managing editor Charles Ornstein wanted to know why experts were wrong when they said U.S. hospitals would be overwhelmed by COVID-19 patients. Here’s what he learned, including what hospitals can do before the next wave.
Postal delays and mistakes have marred primary voting, and after years of budget cuts and plant closures, mail delivery has slowed so much that ballot deadlines in many states are no longer realistic.
